Werfen Life Divests to Focus on the Hemostasis Market

Some large and small healthcare players are shifting their portfolios to focus on the hemostasis analyzer market, which is expected to reach nearly $5 billion by 2021.

Teleflex Keeps Cardio Deals Pumping

It’s been a busy year for mergers and acquisitions in the Medical Device sector. Through December 2, 108 transactions have been announced in 2016, compared with 113 in all of 2015. Target companies specializing in cardiovascular devices make up a small percentage of those deals, but tend to post large prices. So far, $32.8 billion […]

Medical Device Deals Pick Up in October

Only a few weeks into the fourth quarter, and five medical device deals have been announced, putting the year’s total at 95. Abbott (NYSE: ABT) and St. Jude Medical’s (NYSE: STJ) $1.12 divestiture of certain vascular closure and electrophysiology assets is among these five October deals, and the only one to disclose a price. On October […]